Lipodystrophy 20 Years after Initial Descriptions: Body Fat Changes in Persons Living with HIV
Todd T. Brown, MD, PhD
Professor of Medicine and Epidemiology
Division of Endocrinology, Diabetes, and Metabolism
Johns Hopkins University, Baltimore, MD
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2018. All rights reserved.
Todd Brown is a Professor of Medicine and Epidemiology in the Division of Endocrinology, Diabetes, and Metabolism at Johns Hopkins University where he is also the primary endocrine consultant to the Johns Hopkins HIV Clinic. He is a graduate of Columbia University College of Physicians and Surgeons and the Johns Hopkins Bloomberg School of Public Health. He completed his clinical training at Georgetown University and Johns Hopkins. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients, as related to aging. Dr. Brown is particularly interested in the aging-related outcomes of cardiovascular disease, fractures, and frailty in persons living with HIV. He is a co-investigator in the Multicenter AIDS Cohort Study and the AIDS Clinical Trial Group. In the MACS, he is the co-Principal Investigator of the Baltimore/Washington DC site and is the former chair of the Metabolic Working Group. In the ACTG, he has served in leadership positions on multiple observational and interventional studies, including a substudy of REPRIEVE, the large statin trial in low CVD risk, persons living with HIV. He is a member of the Organizing Committee of the International Workshop on Comorbidities and Adverse Drug Reactions in HIV, now in its 20th year. He has published over 170 articles and book chapters on endocrine and metabolic problems and their consequences in HIV-infected persons and has lectured internationally on these topics.
At the completion of this educational session, learners will:
- Understand how legacy effects of drugs used early in the HAART era may affect current health.
- Know how body composition is impacted by ART initiation and what the consequences are.
- Review the evidence that integrase inhibitors lead to weight gain.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
This program will soon be available for CME on the PRN Courses Page at the Clinical Education Initiative Website of the New York State Department of Health, and we will add the link here, as soon as this is available.
PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
